Cystex Max Strength UTI Pain Relief
- Product NDC
- 69693-519
- 11-digit product format
- 696930519
- Labeler code
- 69693
- Product ID
- 69693-519_5ee8c1aa-58b6-9e13-e063-6394a90aba0b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Cystex Max Strength UTI Pain Relief
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Clarion Brands LLC
- Application
- 505G(a)(3)
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2026-07-27
- Substance
- PHENAZOPYRIDINE HYDROCHLORIDE
- Active strength
- 99.5 mg/99.5mg
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Cystex Max Strength UTI Pain Relief
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| PHENAZOPYRIDINE HYDROCHLORIDE | 99.5 mg/99.5mg |
Harmonized UNII identifiers#
UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| 0EWG668W17 | Internal UNII lookup |
Harmonized RxCUI identifiers#
RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table| Identifier | FDA.report destination |
|---|
| 1094147 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
SPL set identifiers page 1 of 1 · 1 matching rows.
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 69693-519-24 | 69693051924 | 2 BLISTER PACK in 1 CARTON (69693-519-24) / 99.5 mg in 1 BLISTER PACK | 2 blister pack | 2026-07-27 | No | No | Current |